Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) shot up 4.2% during trading on Friday. The stock traded as high as $210.27 and last traded at $213.1760. 16,198 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 168,906 shares. The stock had previously closed at $204.59.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on NUTX shares. Lake Street Capital reaffirmed a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Finally, Wall Street Zen downgraded Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Nutex Health presently has an average rating of “Buy” and an average price target of $317.50.
View Our Latest Stock Analysis on Nutex Health
Nutex Health Trading Up 7.5%
Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. As a group, sell-side analysts forecast that Nutex Health Inc. will post 27.58 earnings per share for the current fiscal year.
Insider Buying and Selling at Nutex Health
In related news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the transaction, the director directly owned 400 shares of the company’s stock, valued at approximately $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 44.68% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Nutex Health
Several large investors have recently bought and sold shares of NUTX. Kilter Group LLC acquired a new position in shares of Nutex Health during the second quarter valued at approximately $27,000. Allworth Financial LP purchased a new stake in shares of Nutex Health during the second quarter worth approximately $35,000. Islay Capital Management LLC acquired a new position in Nutex Health in the 4th quarter valued at $34,000. EverSource Wealth Advisors LLC acquired a new position in Nutex Health in the 1st quarter valued at $83,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in Nutex Health in the 4th quarter valued at $165,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Nutex Health Company Profile
Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.
Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.
See Also
- Five stocks we like better than Nutex Health
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
